INTRODUCTION
Greater than 500,000 individuals in the United States die of cancer every year, 1 making it the second leading cause of death. For those patients, dying in a preferred place is an essential component of high-quality cancer care. 2, 3 Research suggests that not only do the vast majority of patients wish to die at home if faced with advanced cancer, 4, 5 but that patient, caregiver, and health system outcomes are worsened with death outside the home. Hospital death has been associated with more physical and emotional distress, worse quality of life, and an increased risk of prolonged grief disorder for caregivers. 6 Family members report that patients who die in a hospital or nursing home setting often have unmet needs for symptom management, emotional support, and respect. 7 Hospital deaths contribute to higher costs near the end of life: approximately 70% of Medicare expenditures ($130 billion) are spent on inpatient services. 8 Conversely, patients who are appropriately enrolled in hospice care report better symptom management and have a greater likelihood of dying in their preferred place 9 and with lower overall costs. 10, 11 Thus, patient-centered and family-centered end-of-life outcomes are improved with the increased use of hospice, 7 with decreased caregiver burden 12 and improved health care economics.
Cancer November 15, 2018 Recent place-of-death studies have provided an incomplete assessment of the population of patients with cancer; the majority of studies use age-restricted sources such as Surveillance, Epidemiology, and End Results (SEER)-Medicare data, [19] [20] [21] [22] [23] [24] which include beneficiaries aged ≥65 years who reside in the limited SEER areas. Given the rise of palliative care and the proliferation of hospice services available over the past 20 years (including to those patients aged <65 years), the objective of the current study was to comprehensively evaluate changes in the place of death for the population of patients with cancer, and to describe any associated health care disparities in place of death across all age groups for the entire US population.
MATERIALS AND METHODS

Data Source
The Centers for Disease Control and Prevention (CDC) Wide-ranging OnLine Data for Epidemiologic Research (WONDER) contains deidentified mortality data for all US counties. It is maintained by the National Center for Health Statistics and is updated on a yearly basis. Death certificates identify a single underlying cause of death and include demographic data along with place of death. 25 These data previously have been used to identify national trends in place of death 15 and cancer mortality. 26 Aggregate patient data are available via online request and include year, age, sex, race, ethnicity, US Census division, county urbanization, and primary cancer. Marital status and educational level are available via downloadable data files.
Study Design
We conducted a retrospective study of all individuals who died of cancer as indicated on their death certificate in the United States from 1999 to 2015. The Duke University Medical Center institutional review board provided a waiver (Pro00045337) for this study because CDC WONDER is publicly available and deidentified.
Patients
All individuals who died of cancer were included. Age at the time of death was reported in 10-year increments, with the exception of the lower and upper ends (reported as birth-14 years and ≥85 years, respectively). All patient ages were included because the population of pediatric patients with cancer has sparse comprehensive data regarding place of death. Urbanization was categorized based on county of residence. Primary cancer was evaluated for the 5 most deadly cancers in the United States (lung, colorectal, pancreas, prostate, and breast cancer, based on the absolute number of cancer deaths) 27 to assess for variability based on cancer diagnosis. Place of death was categorized as the decedent's home, hospital inpatient, nursing facility, hospice facility, other/unknown, and medical facility: other. The official placeof-death categories changed in 2003 when the hospice facility category was introduced. Place-of-death categories are defined only by the location of death and not the services provided. For example, although hospice services may be provided in a nursing facility, the listed place of death would be "nursing facility" and not hospice. The full data set from 1999 was reported to demonstrate comprehensive national trends in the modern era because the last evaluation ended in 1998.
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Statistical Analysis
The primary outcome of the current analysis was to define the associations between independent variables including age group, year of death, sex, marital status, educational level, race, ethnicity, and primary cancer diagnosis and hospital, home, or hospice facility place of death. Year of death was included in multivariate analysis as a continuous variable in the Cox regression analysis and time trends were assessed for significance with coefficient of determination (R 2 ) fit in linear regression. Univariate binary logistic regression was used to model the primary variable of place of death using individual data files from 2003 through 2015 (files for the years 1999 to 2002 were excluded from regression analysis because hospice facility deaths were not documented). All significant variables subsequently were included in multivariate binary logistic regression analyses for each place of death, performed with stepwise selection of variables, allowing for the entry (P<.05) or removal (P<.10) of variables for each iteration. Age group was included in multivariate analyses preferentially over age as a continuous variable because of the nonlinear influence that age was found to have on place of death.
Statistical analyses were performed using SPSS statistical software (version 21; IBM Corporation, Armonk, New York). All comparisons were 2-tailed. For multivariate analysis, Bonferroni correction was assessed for 8 simultaneous comparisons, resulting in a calculated statistical significance threshold of P<.006. Data involving state of residence and urbanization are only available in an aggregate form from the CDC due Cancer November 15, 2018 to concerns for individual privacy. As such, these variables were not available for or included in the above multivariate analysis; they instead were presented in descriptive form.
RESULTS
Patients
In the 17 years between 1999 and 2015, a total of 9,646,498 individuals died of cancer in the United States. Greater than one-half million patients died annually. Table 1 shows patient characteristics and overall cancer mortality trends (including specifics for the sample years 1999, 2007, and 2015) . Slightly greater than one-half of these patients were male (52.1%), and 69.7% died at age ≥65 years. The majority of patients were white (85.9%) and non-Hispanic (94.8%). Lung cancer was the most common primary cancer, causing 27.7% of cancerrelated deaths. Greater than one-half of all cancer deaths (55.6%) were due to lung, colorectal, breast, pancreatic, or prostate cancer, collectively.
Trends in Place of Death
Trends in place of death are noted in 
Disparities in Place of Death by Age and Race
Changes in place of death varied considerably by age and race (Figs. 1A and 1B) . There was an overall downtrend in hospital deaths for all ages and races. In general, throughout the study period, patients with cancer who were aged ≥85 years and those of white race were found to be the least likely to die in a hospital, and patients aged 15 to 24 years and those of black race were the most likely to die in a hospital. There were increased relative disparities noted between age groups over time, with patients aged 15 to 24 years found to be 2.3 times more likely to die in a hospital in 1999 (60 Hospice facility deaths increased rapidly for all ages and racial groups after first being reported in 2003. By 2015, patients aged 45 to 54 years and black patients had the highest percentage of deaths in a hospice facility (15.4% and 14.5%, respectively) and patients aged birth to 14 years and Asian patients had the lowest percentage (3.0% and 9.2%, respectively).
Place of Death by State and Urbanization
Place of death varied by state and urbanization level.
Figures 2A and 2B demonstrate regional differences in place of death at the state level in 2015. Delaware had the highest percentage of deaths at home or in a hospice facility among patients with cancer (70.8%) and North Dakota had the lowest (34.8%). New York had the highest percentage of hospital cancer deaths (40.4%) and Arizona had the lowest (14.5%). Figure 1C shows trends in place of death by county urbanization. From 1999 through 2015, there was an overall downtrend in hospital deaths for all levels of urbanization. Throughout the study period, patients with cancer residing in medium-sized metropolitan areas (population of 250,000-999,999) were the least likely to die in a hospital and were the most likely to die in a hospice facility; patients residing in large central areas (population of ≥1,000,000) were the most likely to die in a hospital, and patients residing in rural areas (population of <10,000) were the least likely to die in a hospice facility.
Regression Analysis for 2003 Through 2015
Deaths due to cancer in the hospital, at home, or in a hospice facility each were modeled using individual Cancer November 15, 2018 case data from the 13 years with complete information regarding place of death (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) . Index cancers (lung, colorectal, pancreatic, prostate, and breast cancers) were included as well as sociodemographic variables. All examined variable categories were found to be associated with place of death on univariate analysis (P<.05) and thus were included in modeled analysis. On multivariate analysis, all variables (age, year of death, sex, marital status, educational level, race, ethnicity, and primary cancer) were found to be statistically significant for each modeled result (P<.006), although not all specific covariates were significant. 
DISCUSSION
In this study of all reported cancer deaths in the United States over the past 17 years, hospital cancer deaths decreased by approximately one-third, with a commensurate increase in home and hospice facility deaths. Despite this overall trend, disparities in place of death for young and/or black patients appear to be widening when compared with older and/or white patients.
Improving care for patients with cancer at the end of life has been an evolving research and education priority over the past 20 years. 28, 29 The American Society of Clinical Oncology published a special article in 1998 highlighting the integration of palliative care and hospice use as essential to high-quality cancer care at the end of life. 30 Updated guidelines recommend the integration of specialist palliative care into routine cancer care. 31 Efforts to increase awareness of these services are important, because research has demonstrated that routine assessment of patient values and wishes for end-of-life care is both feasible [32] [33] [34] and effective at reducing hospital deaths. 35 The Medicare hospice benefit was enacted by Congress in 1982 and provides funding for hospice services 36 ; since that time, hospice has become at least a $15.9-billion business 8 focused on improving end-oflife care. 37, 38 Hospice can be provided either at home for those with a primary caregiver and controlled symptoms or in a hospice facility for those who may need services at the level of acute general inpatient care. In the last 20 years, there has been a cultural shift from "quantity of care" to optimizing the "quality of care." Although the current study did not specifically track hospice enrollment, the increased rates of home and hospice facility deaths likely reflect increased use. Unfortunately, hospice access has been variable across the United States, with the Dartmouth Atlas reporting large geographic variations in access and use. 39, 40 These known significant gaps in hospice availability 41 may explain the regional disparities observed with regard to place of death.
In addition to access to local resources, appropriate home caregiver support is essential to the concept and execution of home hospice. Caregivers play a vital unpaid role in the US health care system, 42 and understanding this role demonstrates how marriage can be an important component of end-of-life care and place of death. Single patients may not have the full benefit of family support (at least in terms of spouse and/or children) that a married or widowed patient may have available. This potential lack of a caregiver partially may explain their lower rates of home death and relative higher rates of hospital and hospice facility death.
The results of the current study highlight significant racial disparities with regard to place of death, with nonwhite, Hispanic patients with cancer significantly more likely to die in a hospital. Potential barriers to home or hospice death include patient and caregiver preference, available caregiver/family support, and provider referral patterns. 43, 44 There are known racial differences in many important end-of-life metrics for black patients. This may be due in part to a preference for more aggressive care at the end of life and a distrust of the health care system. 45 Black patients are less likely to have do-not-resuscitate orders, 46 are less likely to have family care at home, 47 and to have lower rates of use of home hospice. 48 Prior SEERMedicare research has demonstrated similar disparities Cancer November 15, 2018 in care for Asian American patients. 49 Unfortunately, there has been little research focused on American Indian patients, who were shown in the current study to have significant place-of-death disparities in home and hospice death. Although all racial groups demonstrated a temporal decrease for hospital death rates within the last 17 02 03 04 05 06 07 08 09 10 11 12 13 14 15 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 Cancer November 15, 2018 years, the results of the current study highlight that large disparities remain. There were important trends in place of death noted among different age groups. Age disparities are poorly studied in terms of hospice use and place of death. Previous research regarding place of death has been limited primarily to patients aged ≥65 years, omitting young Americans, who may have very different treatment courses and are more likely to receive aggressive care 50, 51 and die in a hospital. 52 For example, one study using Medicare claims demonstrated that the hospital death rate for patients with cancer was 22% in 2010 53 ; the current study, which included all patients who died of cancer in the United States in 2010, indicated that this rate was higher at 28%. Other research has suggested that older age is predictive of hospice enrollment 54 or less aggressive end-of-life care. 55 The results of the current study demonstrate that place of death varies significantly by age group, with older patients more likely to Cancer November 15, 2018 die in a nursing facility and younger patients more likely to die in a hospital. This may reflect the level of care and social support needed for the very old and very young. This information is especially important given the lack of end-of-life quality metrics for pediatric 56 and younger patients 57 and the overall need to improve cancer care for the aging. 58, 59 Indeed, given the aging of the US population, 60 the findings of the current study may have important policy implications for how high-quality end-of-life care will be provided to those who lack social support and a caregiver. By 2015, there were an additional approximately 25,000 patients aged >85 years who died of cancer.
Rates of hospice use vary widely based on the primary cancer diagnosis. 61 Patients with pancreatic cancer are reported to have high rates of hospice use, 62 potentially commensurate with their overall poor prognosis. The current study highlights that patients with breast cancer may have unmet needs when compared with patients with other cancers because they are less likely to die at home or in a hospice facility. Further research is needed to better elucidate these trends.
The current study has several limitations. The first is the potential inaccuracy of death certificate cause of death; a 1981 study found that up to 35% of cancer deaths were miscoded on the death certificate, 63 although the majority of errors appeared to be within subcategories (eg, rectal cancer recorded as colon cancer), which would not affect the current analysis. In addition, because coding for hospice as a place of death was included only after 2002, there is a possibility that some of the subsequent increase may be due to ascertainment bias, although this likely would be present only for the first few years. There were many shifting demographics throughout the 17-year study period, with deaths among white patients, non-Hispanic patients, and patients with lung cancer decreasing as deaths among older patients and those with pancreatic cancer increased. These changes likely reflect the evolving face of cancer care in the United States, with changes in the general population, diagnosis, and treatment causing shifts that even careful analysis may not control for fully. The current study also evaluated only specific (and limited) decedent characteristics influencing place of death. It is widely understood that access to and use of hospice care varies via income, 64 insurance, 48, 65, 66 and county-level resources, 67,68 which were not captured in the current study. The level of care provided leading up to death also was not categorized herein; it is possible that a hospice patient may have had multiple weeks at home prior to his or her ultimate admission and hospital death. However, arguably, the potential disruption of a transition from home hospice to ultimate hospital death does not fit with the goal of a "good death." Last, the coded place-of-death categories are fairly broad and may not fully capture services provided in end-of-life care. For example, patient death on a palliative care service or hospice floor in a hospital still would be considered as "hospital death" in terms of place of death. In addition, nearly one-third of hospice services are provided at nursing and long-term care facilities 69 ; unfortunately, in the current study, a patient dying in a nursing facility with hospice services cannot be distinguished from a patient who died at a skilled nursing facility aligned with standard care. Its limitations notwithstanding, the current study represents the most complete description of where cancer deaths in the United States occur in the modern era. These findings represent the totality of cancer deaths, >9 million individuals, and help focus on the place of death at a national level. The current study highlights significant populations with place-of-death disparities that have persisted over time, and specific groups for whom the gap appears to have even widened.
CONCLUSIONS
In the United States, the overall rate of hospital deaths from cancer has decreased by approximately one-third over the last 20 years. Commensurately, there has been a rapid increase in the number of deaths in hospice facilities, and a slower but appreciable rise in deaths occurring at home. However, despite broad improvements in place of death across all patients, many sociodemographic groups continue to be less likely to die at home or in a hospice facility. Significant efforts are required to decrease these disparities at the end of life. Improving clinician and patient education and other targeted outreach efforts to increase the rates of use of palliative care and hospice services may improve goal-concordant care for these potentially vulnerable populations.
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